Increased cardiovascular death with single antiplatelet therapy in oral anticoagulation-treated chronic coronary artery disease: meta-analysis of randomized trials

In chronic CAD requiring anticoagulation, OAC monotherapy vs OAC+SAPT reduced cardiovascular mortality and major bleeding without an excess in nonfatal thrombotic events, generally supporting OAC alone as the preferred long‑term strategy in this patient population.